ask="0.900"
ask_size="1800"
average_daily_volume="624638"
bid="0.560"
bid_size="900"
book_value="0.606"
change="+0.019"
change_from_200_day_moving_average="-0.887"
change_from_50_day_moving_average="-0.095"
change_from_52_week_high="-4.041"
change_From_52_week_low="0.389"
change_in_percent="+2.184%"
close="0.889"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.237"
ebitda="-8.78M"
eps_estimate_current_year="-1.120"
eps_estimate_next_quarter="-0.250"
eps_estimate_next_year="-0.320"
ex_dividend_date="N/A"
float_shares="7029000"
high="0.899"
high_52_weeks="4.930"
last_trade_date="3/16/2017"
last_trade_price="0.889"
last_trade_size="345"
last_trade_time="4:00pm"
low="0.830"
low_52_weeks="0.500"
market_capitalization="6.35M"
moving_average_200_day="1.776"
moving_average_50_day="0.984"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="1.000"
open="0.899"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-49.932%"
percent_change_from_50_day_moving_average="-9.654%"
percent_change_from_52_week_high="-81.967%"
percent_change_from_52_week_low="+77.800%"
previous_close="0.870"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.436"
price_per_sales="2.430"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="1.240"
stock_exchange="NCM"
symbol="OPXA"
volume="75647"
weeks_range_52="0.500 - 4.930"
